CARGO Therapeutics Statistics
Total Valuation
CRGX has a market cap or net worth of $188.60 million. The enterprise value is -$113.61 million.
Important Dates
The next estimated earnings date is Friday, May 16, 2025, after market close.
| Earnings Date | May 16, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CRGX has 46.11 million shares outstanding. The number of shares has increased by 191.07% in one year.
| Current Share Class | 46.11M |
| Shares Outstanding | 46.11M |
| Shares Change (YoY) | +191.07% |
| Shares Change (QoQ) | +0.04% |
| Owned by Insiders (%) | 0.52% |
| Owned by Institutions (%) | 85.66% |
| Float | 27.97M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 0.66 |
| P/TBV Ratio | 0.66 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 6.30, with a Debt / Equity ratio of 0.11.
| Current Ratio | 6.30 |
| Quick Ratio | 6.21 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -65.94% and return on invested capital (ROIC) is -33.02%.
| Return on Equity (ROE) | -65.94% |
| Return on Assets (ROA) | -30.07% |
| Return on Invested Capital (ROIC) | -33.02% |
| Return on Capital Employed (ROCE) | -60.79% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.29M |
| Employee Count | 167 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -78.68% in the last 52 weeks.
| Beta (5Y) | n/a |
| 52-Week Price Change | -78.68% |
| 50-Day Moving Average | 4.19 |
| 200-Day Moving Average | 12.74 |
| Relative Strength Index (RSI) | 39.60 |
| Average Volume (20 Days) | 736,554 |
Short Selling Information
The latest short interest is 2.54 million, so 5.51% of the outstanding shares have been sold short.
| Short Interest | 2.54M |
| Short Previous Month | 2.62M |
| Short % of Shares Out | 5.51% |
| Short % of Float | 9.08% |
| Short Ratio (days to cover) | 2.90 |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -188.71M |
| Pretax Income | n/a |
| Net Income | -216.19M |
| EBITDA | -185.93M |
| EBIT | -188.71M |
| Earnings Per Share (EPS) | -$4.63 |
Full Income StatementBalance Sheet
The company has $318.84 million in cash and $30.45 million in debt, giving a net cash position of $300.83 million or $6.52 per share.
| Cash & Cash Equivalents | 318.84M |
| Total Debt | 30.45M |
| Net Cash | 300.83M |
| Net Cash Per Share | $6.52 |
| Equity (Book Value) | 282.46M |
| Book Value Per Share | 6.13 |
| Working Capital | 273.26M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$147.29 million and capital expenditures -$3.54 million, giving a free cash flow of -$150.83 million.
| Operating Cash Flow | -147.29M |
| Capital Expenditures | -3.54M |
| Free Cash Flow | -150.83M |
| FCF Per Share | -$3.27 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |